Trinidad and Tobago currently reports an pharmaceuticals, medicinal chemicals, seasonally adjusted index of 139.0, which represents an increase of 1.5 (1.1%) from 2023 Q4.
Pharmaceuticals, medicinal chemicals, seasonally adjusted index in Trinidad and Tobago
No matching regions
Data availability:
Regions:
82
Date range: 2005 Q1 to 2024 Q1
Points:
5,455
Measure:
Index
Similar regions to Trinidad and Tobago
Pharmaceuticals, medicinal chemicals
More indicators for Trinidad and Tobago
Trinidad and Tobago Pharmaceuticals, medicinal chemicals between 2005 Q1 and 2024 Q1
Period | Pharmaceuticals, medicinal chemicals | Change |
---|---|---|
2024 Q1 | 139.0 | +1.5 |
2023 Q4 | 137.5 | -1.6 |
2023 Q3 | 139.1 | -1.2 |
2023 Q2 | 140.3 | +5.6 |
2023 Q1 | 134.7 | +0.2 |
2022 Q4 | 134.5 | +1.4 |
2022 Q3 | 133.1 | -1.2 |
2022 Q2 | 134.3 | +3.5 |
2022 Q1 | 130.8 | +4.5 |
2021 Q4 | 126.3 | -0.7 |
2021 Q3 | 127.0 | -1.9 |
2021 Q2 | 128.9 | +2.7 |
2021 Q1 | 126.2 | +0.7 |
2020 Q4 | 125.5 | +3.2 |
2020 Q3 | 122.3 | +6.6 |
2020 Q2 | 115.7 | -1.7 |
2020 Q1 | 117.4 | -0.1 |
2019 Q4 | 117.5 | +2.7 |
2019 Q3 | 114.8 | +1.3 |
2019 Q2 | 113.5 | -1.5 |
2019 Q1 | 115.0 | +0.6 |
2018 Q4 | 114.4 | +6.1 |
2018 Q3 | 108.3 | -3.9 |
2018 Q2 | 112.2 | +1.0 |
2018 Q1 | 111.2 | -2.8 |
2017 Q4 | 114.0 | +3.3 |
2017 Q3 | 110.7 | +4.4 |
2017 Q2 | 106.3 | +2.6 |
2017 Q1 | 103.7 | +0.7 |
2016 Q4 | 103.0 | +3.5 |
2016 Q3 | 99.5 | -3.3 |
2016 Q2 | 102.8 | +3.2 |
2016 Q1 | 99.6 | -0.4 |
2015 Q4 | 100.0 | +1.7 |
2015 Q3 | 98.3 | -2.6 |
2015 Q2 | 100.9 | +0.2 |
2015 Q1 | 100.7 | -1.4 |
2014 Q4 | 102.1 | -6.6 |
2014 Q3 | 108.7 | +0.6 |
2014 Q2 | 108.1 | -1.1 |
2014 Q1 | 109.2 | -1.9 |
2013 Q4 | 111.1 | -5.9 |
2013 Q3 | 117.0 | +0.6 |
2013 Q2 | 116.4 | -2.0 |
2013 Q1 | 118.4 | +5.3 |
2012 Q4 | 113.1 | -2.8 |
2012 Q3 | 115.9 | +1.1 |
2012 Q2 | 114.8 | -20.1 |
2012 Q1 | 134.9 | -4.2 |
2011 Q4 | 139.1 | +40.0 |
2011 Q3 | 99.1 | +1.5 |
2011 Q2 | 97.6 | -27.9 |
2011 Q1 | 125.5 | +0.1 |
2010 Q4 | 125.4 | -9.4 |
2010 Q3 | 134.8 | +36.7 |
2010 Q2 | 98.1 | -28.9 |
2010 Q1 | 127.0 | -2.9 |
2009 Q4 | 129.9 | +9.7 |
2009 Q3 | 120.2 | +7.4 |
2009 Q2 | 112.8 | -1.3 |
2009 Q1 | 114.1 | -2.6 |
2008 Q4 | 116.7 | +1.3 |
2008 Q3 | 115.4 | -4.8 |
2008 Q2 | 120.2 | +0.4 |
2008 Q1 | 119.8 | -3.5 |
2007 Q4 | 123.3 | -3.3 |
2007 Q3 | 126.6 | -5.6 |
2007 Q2 | 132.2 | -5.2 |
2007 Q1 | 137.4 | +11.6 |
2006 Q4 | 125.8 | -13.6 |
2006 Q3 | 139.4 | -0.1 |
2006 Q2 | 139.5 | -4.5 |
2006 Q1 | 144.0 | +1.4 |
2005 Q4 | 142.6 | -1.9 |
2005 Q3 | 144.5 | -1.0 |
2005 Q2 | 145.5 | -1.9 |
2005 Q1 | 147.4 |